Integra LifeSciences Holdings Corporation (IART)
IART Stock Price Chart
Explore Integra LifeSciences Holdings Corporation interactive price chart. Choose custom timeframes to analyze IART price movements and trends.
IART Company Profile
Discover essential business fundamentals and corporate details for Integra LifeSciences Holdings Corporation (IART) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Devices
IPO Date
16 Aug 1995
Employees
4.40K
Website
https://www.integralife.comCEO
Mojdeh Poul
Description
Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural repair products, cerebral spinal fluid management devices, intracranial monitoring equipment, and cranial stabilization equipment; and surgical headlamps and instrumentation, as well as asset management software and support, and after-market services. It also sells approximately 40,000 instrument patterns, and surgical and lighting products to hospitals and surgery centers, as well as dental, podiatry, and veterinary offices. In addition, the company provides regenerative technology products for the treatment of acute and chronic wounds; and surgical tissue repair products for hernia repair, peripheral nerve repair and protection, and tendon repair. Further, it offers skin and wound repair, plastics and surgical reconstruction products, bone grafts, and nerve and tendon repair products. The company offers its products directly through various sales forces and other distribution channels to the hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers, and health care providers in the United States, Europe, Asia Pacific, and internationally. Integra LifeSciences Holdings Corporation was incorporated in 1989 and is headquartered in Princeton, New Jersey.
IART Financial Timeline
Browse a chronological timeline of Integra LifeSciences Holdings Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 23 Feb 2026
Upcoming earnings on 3 Nov 2025
EPS estimate is $0.46.
Earnings released on 31 Jul 2025
EPS came in at $0.45 surpassing the estimated $0.43 by +4.65%, while revenue for the quarter reached $415.61M , beating expectations by +0.31%.
Earnings released on 5 May 2025
EPS came in at $0.41 falling short of the estimated $0.43 by -4.65%, while revenue for the quarter reached $382.65M , missing expectations by -4.95%.
Earnings released on 25 Feb 2025
EPS came in at $0.97 surpassing the estimated $0.86 by +12.79%, while revenue for the quarter reached $442.65M , beating expectations by +7.51%.
Earnings released on 4 Nov 2024
EPS came in at $0.41 surpassing the estimated $0.39 by +5.13%, while revenue for the quarter reached $380.83M , missing expectations by -14.51%.
Earnings released on 29 Jul 2024
EPS came in at $0.63 surpassing the estimated $0.62 by +1.61%, while revenue for the quarter reached $418.18M , beating expectations by +1.22%.
Earnings released on 6 May 2024
EPS came in at $0.55 matching the estimated $0.55, while revenue for the quarter reached $368.87M , beating expectations by +1.91%.
Earnings released on 28 Feb 2024
EPS came in at $0.89 falling short of the estimated $0.90 by -1.11%, while revenue for the quarter reached $397.04M , missing expectations by -0.58%.
Earnings released on 25 Oct 2023
EPS came in at $0.76 falling short of the estimated $0.78 by -2.56%, while revenue for the quarter reached $382.42M , missing expectations by -1.21%.
Earnings released on 26 Jul 2023
EPS came in at $0.71 surpassing the estimated $0.57 by +24.56%, while revenue for the quarter reached $381.27M , missing expectations by -1.88%.
Earnings released on 26 Apr 2023
EPS came in at $0.74 matching the estimated $0.74, while revenue for the quarter reached $380.85M , beating expectations by +2.05%.
Earnings released on 22 Feb 2023
EPS came in at $0.94 surpassing the estimated $0.93 by +1.08%, while revenue for the quarter reached $398.02M , beating expectations by +0.02%.
Earnings released on 26 Oct 2022
EPS came in at $0.86 surpassing the estimated $0.72 by +19.44%, while revenue for the quarter reached $385.19M , beating expectations by +1.81%.
Earnings released on 27 Jul 2022
EPS came in at $0.82 surpassing the estimated $0.80 by +2.50%, while revenue for the quarter reached $397.82M , beating expectations by +0.62%.
Earnings released on 27 Apr 2022
EPS came in at $0.74 surpassing the estimated $0.68 by +8.82%, while revenue for the quarter reached $376.64M , beating expectations by +3.93%.
Earnings released on 23 Feb 2022
EPS came in at $0.84 surpassing the estimated $0.83 by +1.20%, while revenue for the quarter reached $405.52M , beating expectations by +0.24%.
Earnings released on 2 Nov 2021
EPS came in at $0.86 surpassing the estimated $0.72 by +19.44%, while revenue for the quarter reached $386.86M , beating expectations by +0.34%.
Earnings released on 28 Jul 2021
EPS came in at $0.79 surpassing the estimated $0.67 by +17.91%, while revenue for the quarter reached $389.99M , beating expectations by +1.15%.
Earnings released on 28 Apr 2021
EPS came in at $0.69 surpassing the estimated $0.57 by +21.05%, while revenue for the quarter reached $360.07M , beating expectations by +2.89%.
Earnings released on 18 Feb 2021
EPS came in at $0.84 surpassing the estimated $0.73 by +15.07%, while revenue for the quarter reached $388.65M , beating expectations by +17.74%.
Earnings released on 28 Oct 2020
EPS came in at $0.80 surpassing the estimated $0.57 by +40.35%, while revenue for the quarter reached $370.23M , beating expectations by +48.15%.
IART Stock Performance
Access detailed IART performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.